Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Capital Leases (2019 - 2023)

Historic Capital Leases for Serina Therapeutics (SER) over the last 2 years, with Q4 2023 value amounting to $1000.0.

  • Serina Therapeutics' Capital Leases changed N/A to $1000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $1000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Serina Therapeutics reported Capital Leases of $1000.0 as of Q4 2023.
  • In the past 5 years, Serina Therapeutics' Capital Leases registered a high of $221000.0 during Q2 2019, and its lowest value of $1000.0 during Q4 2023.